End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis
Comment on "BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis." [American Journal of Respiratory and Critical Care Medicine, 2011]
4-5
Noble, Paul W.
ddf91f7c-f39e-4db3-b47f-2164bc293f8e
Richeldi, Luca
47177d9c-731a-49a1-9cc6-4ac8f6bbbf26
Kaminski, Naftali
0565895f-8345-4bec-bd33-0618bcf7b81c
1 July 2011
Noble, Paul W.
ddf91f7c-f39e-4db3-b47f-2164bc293f8e
Richeldi, Luca
47177d9c-731a-49a1-9cc6-4ac8f6bbbf26
Kaminski, Naftali
0565895f-8345-4bec-bd33-0618bcf7b81c
Noble, Paul W., Richeldi, Luca and Kaminski, Naftali
(2011)
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis.
American Journal of Respiratory and Critical Care Medicine, 184 (1), .
(doi:10.1164/rccm.201105-0813ED).
(PMID:21474646)
Abstract
Comment on "BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis." [American Journal of Respiratory and Critical Care Medicine, 2011]
This record has no associated files available for download.
More information
Published date: 1 July 2011
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 369078
URI: http://eprints.soton.ac.uk/id/eprint/369078
ISSN: 1073-449X
PURE UUID: bd7d768a-325a-4617-b609-69ec398db5f2
Catalogue record
Date deposited: 24 Sep 2014 11:25
Last modified: 14 Mar 2024 17:57
Export record
Altmetrics
Contributors
Author:
Paul W. Noble
Author:
Luca Richeldi
Author:
Naftali Kaminski
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics